Nura Peptide
15 mg vial
- Vendor score
- 88/100
- Effective vial price
- Not available
- Effective price per mg
- Not available
Retatrutide/Cagrilintide Blend is a multi-compound blend; its components need to be evaluated separately as well as together.
Also known as cagri/reta · reta / cagri · reta/cagri · retatrutide/cagrilintide
Research shortlist · Sep 12, 2026
These research selections use the same basis: 15 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
15 mg vial
15 mg vial
15 mg vial
What it is
Retatrutide/Cagrilintide Blend is a multi-compound blend; its components need to be evaluated separately as well as together.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
Retatrutide/Cagrilintide Blend is commonly sold or discussed for the combined goals associated with its listed ingredients. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
1 of 1 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| EZ PeptidesVendor grade | Grade A- | 1 | 1 | $106.20Automatic buy x get y free · listed $11815 mg vial · compare →Observed Sep 21, 2026 | View → |
| Nura PeptideVendor grade | Grade A- | Not available | Not available | Not availableNo market observation | View → |
| Peptide PlugsVendor grade | Grade A- | Not available | Not available | Not availableNo market observation | View → |
| GenPeptideVendor grade | Grade A- | Not available | Not available | Not availableNo market observation | View → |
| Southern AminosVendor grade | Grade A- | Not available | Not available | Not availableNo market observation | View → |
| Ameano PeptidesVendor grade | Grade B+ | 1 | 1 | $13515 mg vial · compare →Observed Sep 21, 2026 | View → |
| Glacier AminosVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| VAYNVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| AIO PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.